BrainStorm Cell Therapeutics
BCLI
#10991
Rank
ยฃ6.32 M
Marketcap
ยฃ0.57
Share price
0.66%
Change (1 day)
10.69%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -ยฃ7.89 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ7.73 Million, an increase over its 2024 earnings that were of -ยฃ8.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ7.89 Million2.12%
2025 -ยฃ7.73 Million-11.32%
2024 -ยฃ8.72 Million-32.39%
2023 -ยฃ12.89 Million-29.18%
2022 -ยฃ18.2 Million-0.74%
2021 -ยฃ18.34 Million-23.12%
2020 -ยฃ23.85 Million36.8%
2019 -ยฃ17.43 Million66.71%
2018 -ยฃ10.46 Million181.66%
2017 -ยฃ3.72 Million-0.6%
2016 -ยฃ3.74 Million-41.31%
2015 -ยฃ6.37 Million-8.22%
2014 -ยฃ6.94 Million89.74%
2013 -ยฃ3.66 Million42.27%
2012 -ยฃ2.57 Million-12.45%
2011 -ยฃ2.94 Million63.04%
2010 -ยฃ1.8 Million35.52%
2009 -ยฃ1.33 Million-48.99%
2008 -ยฃ2.61 Million-44.39%
2007 -ยฃ4.68 Million
2005 -ยฃ2.43 Million-91.44%
2004 -ยฃ28.32 Million94007.62%
2003 -ยฃ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
ยฃ0.75 B-9,712.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.47 Billion 18,480.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-ยฃ0.6 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.68 Billion 8,396.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ0.11 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-ยฃ0.2 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA